FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113293345> ?p ?o ?g. }

• W2113293345 endingPage "164" @default.
• W2113293345 startingPage "160" @default.
• W2113293345 abstract "Objective. To compare the usage of bupropion hydrochloride and nicotine replacement in Australia between 2001 and 2005. Design and Setting. We analysed aggregate data on the utilisation of: (1) bupropion under the Pharmaceutical Benefit Scheme (PBS) between 2001 and 2005; (2) bupropion and nicotine replacement therapy (NRT) on the Repatriation Pharmaceutical Benefit Scheme (RPBS) between 1995 and 2005; and (3) NRT aggregate sales data from GlaxoSmithKline for 2001–05. The National Drug Strategy Household Survey (NDSHS) 2004 was used to estimate the proportion of smokers who received a bupropion prescription in each year. Main Outcome Measures. Numbers of annual prescriptions for bupropion on the PBS and buproprion and NRT on the RPBS; annual sales figures on NRT patches (2001–05); and the estimated proportion of Australian smokers who used bupropion in 2003. Results. The number of bupropion prescriptions on the PBS peaked at 351 772 in 2001 (costing the PBS $83 million). This declined by 72% to 97 173 in 2005 (a cost of $12 million). The estimated percentage of smokers in Australia who used bupropion in a year fell from 11% in 2001 to 3.6% in 2005. The annual number of bupropion prescriptions on the RPBS fell from 3786 in 2001 to 1173 in 2005, while there was no change in the number of NRT prescriptions (3793 in 2001 and 3886 in 2005). Sales data from the leading market supplier of NRT also indicated that NRT use continued to grow in Australia while bupropion use declined. Conclusions. Bupropion usage has fallen by 72% since a peak in the year of first listing on the PBS, while the utilisation of NRTs appears to have increased, despite the price differential in favour of bupropion. Implications. Given the greater interest among smokers in NRT than bupropion (and evidence of the effectiveness and cost-effectiveness of NRT), the Australian government should reconsider its decision not to list NRT on the PBS." @default.
• W2113293345 created "2016-06-24" @default.
• W2113293345 creator A5031345113 @default.
• W2113293345 creator A5053783025 @default.
• W2113293345 creator A5053840112 @default.
• W2113293345 date "2008-03-01" @default.
• W2113293345 modified "2023-09-23" @default.
• W2113293345 title "Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05" @default.
• W2113293345 cites W2039772431 @default.
• W2113293345 cites W2101181764 @default.
• W2113293345 cites W4211019521 @default.
• W2113293345 cites W4211247657 @default.
• W2113293345 cites W4292672078 @default.
• W2113293345 doi "https://doi.org/10.1080/09595230701829462" @default.
• W2113293345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18264876" @default.
• W2113293345 hasPublicationYear "2008" @default.
• W2113293345 type Work @default.
• W2113293345 sameAs 2113293345 @default.
• W2113293345 citedByCount "6" @default.
• W2113293345 countsByYear W21132933452012 @default.
• W2113293345 countsByYear W21132933452015 @default.
• W2113293345 countsByYear W21132933452016 @default.
• W2113293345 crossrefType "journal-article" @default.
• W2113293345 hasAuthorship W2113293345A5031345113 @default.
• W2113293345 hasAuthorship W2113293345A5053783025 @default.
• W2113293345 hasAuthorship W2113293345A5053840112 @default.
• W2113293345 hasConcept C118552586 @default.
• W2113293345 hasConcept C142724271 @default.
• W2113293345 hasConcept C194828623 @default.
• W2113293345 hasConcept C2426938 @default.
• W2113293345 hasConcept C2777843972 @default.
• W2113293345 hasConcept C2779547902 @default.
• W2113293345 hasConcept C2779908668 @default.
• W2113293345 hasConcept C2780478649 @default.
• W2113293345 hasConcept C71924100 @default.
• W2113293345 hasConcept C98274493 @default.
• W2113293345 hasConceptScore W2113293345C118552586 @default.
• W2113293345 hasConceptScore W2113293345C142724271 @default.
• W2113293345 hasConceptScore W2113293345C194828623 @default.
• W2113293345 hasConceptScore W2113293345C2426938 @default.
• W2113293345 hasConceptScore W2113293345C2777843972 @default.
• W2113293345 hasConceptScore W2113293345C2779547902 @default.
• W2113293345 hasConceptScore W2113293345C2779908668 @default.
• W2113293345 hasConceptScore W2113293345C2780478649 @default.
• W2113293345 hasConceptScore W2113293345C71924100 @default.
• W2113293345 hasConceptScore W2113293345C98274493 @default.
• W2113293345 hasIssue "2" @default.
• W2113293345 hasLocation W21132933451 @default.
• W2113293345 hasLocation W21132933452 @default.
• W2113293345 hasOpenAccess W2113293345 @default.
• W2113293345 hasPrimaryLocation W21132933451 @default.
• W2113293345 hasRelatedWork W106464869 @default.
• W2113293345 hasRelatedWork W1980408305 @default.
• W2113293345 hasRelatedWork W2013065612 @default.
• W2113293345 hasRelatedWork W2061491441 @default.
• W2113293345 hasRelatedWork W2067805169 @default.
• W2113293345 hasRelatedWork W2157675023 @default.
• W2113293345 hasRelatedWork W2412802366 @default.
• W2113293345 hasRelatedWork W2416679134 @default.
• W2113293345 hasRelatedWork W2462333200 @default.
• W2113293345 hasRelatedWork W266448251 @default.
• W2113293345 hasVolume "27" @default.
• W2113293345 isParatext "false" @default.
• W2113293345 isRetracted "false" @default.
• W2113293345 magId "2113293345" @default.
• W2113293345 workType "article" @default.